Study guide

11.3 Right Ventricle to Pulmonary Artery (RV-PA) Conduits & Ross Procedure

ARDMS Pediatric Echocardiography RDCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Normal Great Arteries & Coronary Origins

1.1 Aortic Arch, Branching Patterns & Conotruncal Anatomy 1.2 Normal Coronary Artery Anatomy, Origins & Variants 1.3 Pulmonary Artery Branching & Ductus Arteriosus Geometry

2 Chapter 2: Systemic and Pulmonary Veins & Cardiac Chambers

2.1 Systemic Venous Connections: IVC, SVC, Hepatic Veins & Coronary Sinus 2.2 Pulmonary Venous Drainage, Left Atrium & Ridge Anatomy 2.3 Right and Left Ventricular Anatomy & Morphologic Characteristics

3 Chapter 3: Cardiac Valves, Transitional Circulation & Situs

3.1 Atrioventricular and Semilunar Valve Morphology & Subvalvular Apparatus 3.2 Fetal to Neonatal Transitional Circulation, Persistent Fetal Shunts & Visceral Situs

4 Chapter 4: Pediatric Cardiomyopathies & Cardiotoxicity

4.1 Hypertrophic and Restrictive Cardiomyopathy in Children 4.2 Dilated, Non-Compaction & Arrhythmogenic Ventricular Cardiomyopathies 4.3 Anthracycline Cardiotoxicity, Neuromuscular Dystrophies & Metabolic Infiltration

5 Chapter 5: Inflammatory, Hypertensive & Systemic Acquired Conditions

5.1 Kawasaki Disease & Pediatric Coronary Aneurysm Surveillance 5.2 Infective Endocarditis, Rheumatic Heart Disease & Pericardial Effusion 5.3 Pediatric Pulmonary Arterial Hypertension, Cor Pulmonale & Eisenmenger Syndrome 5.4 Systemic Hypertension & Hypertensive Heart Disease in Children 5.5 Heritable Connective Tissue Disorders & Pediatric Aortopathy

6 Chapter 6: Septal Defects & Atrioventricular Canal Anomalies

6.1 Atrial Septal Defects: Secundum, Primum, Sinus Venosus & Unroofed Coronary Sinus 6.2 Ventricular Septal Defects: Membranous, Muscular, Inlet & Malalignment 6.3 Complete, Partial & Transitional Atrioventricular Canal (AV Septal) Defects

7 Chapter 7: Conotruncal Anomalies & Outflow Malformations

7.1 Tetralogy of Fallot, Absent Pulmonary Valve & Pulmonary Atresia with VSD 7.2 D-Transposition of the Great Arteries & L-Transposition (ccTGA) 7.3 Truncus Arteriosus, Double Outlet Right Ventricle (DORV) & Aortopulmonary Window

8 Chapter 8: Left and Right Heart Obstructive & Valvular Defects

8.1 Coarctation of the Aorta, Interrupted Aortic Arch & Shone Complex 8.2 Aortic Valve Stenosis, Subaortic Membranes, Supravalvular AS & Bicuspid Aorta 8.3 Ebstein Anomaly, Tricuspid Dysplasia & Congenital Pulmonary Stenosis/Atresia

9 Chapter 9: Venous & Ductal Anomalies, Coronaries, Single Ventricle, Cardiac Masses & Genetic Syndromes

9.1 Total & Partial Anomalous Pulmonary Venous Connection (TAPVC/PAPVC) 9.2 Patent Ductus Arteriosus & Vascular Rings / Slings 9.3 Anomalous Coronary Origins: ALCAPA, ARCAPA, Course & Fistulas 9.4 Hypoplastic Left Heart Syndrome (HLHS) & Tricuspid Atresia Anatomy 9.5 Cardiac Tumors & Intracardiac Masses in Children 9.6 Cor Triatriatum, Systemic Venous Anomalies & Heterotaxy Syndromes 9.7 Genetic Syndromes & Their Associated Cardiac Lesions

10 Chapter 10: Surgical Repair of Septal Defects, TOF & Arch Lesions

10.1 Postoperative ASD, VSD & AV Canal Repair Assessment 10.2 Postoperative Tetralogy of Fallot Repair & Pulmonary Valve Replacement 10.3 Postoperative Coarctation Repair, Arch Reconstruction & Residual Gradients

11 Chapter 11: Great Artery Switches, Baffles & Conduit Operations

11.1 Arterial Switch Operation (Jatene) & Lecompte Maneuver Evaluation 11.2 Atrial Inversion Baffles (Mustard/Senning) & Rastelli Repair 11.3 Right Ventricle to Pulmonary Artery (RV-PA) Conduits & Ross Procedure

12 Chapter 12: Single Ventricle Palliation, TAPVC Repair, Transplants & Devices

12.1 Norwood Stage I Reconstruction, Sano Shunts & Blalock-Taussig Shunts 12.2 Superior Cavopulmonary Connection (Bidirectional Glenn / Hemi-Fontan) 12.3 Total Cavopulmonary Connection (Fontan Completion: Extracardiac & Lateral Tunnel) 12.4 Postoperative TAPVC Repair, Pediatric Heart Transplantation & Ventricular Assist Devices 12.5 Implantable Devices, Lines & Lead-Related Echocardiographic Findings 12.6 Transcatheter Interventions: Balloon Valvuloplasty, Stents & Valve Implantation

13 Chapter 13: Acoustic Windows, Instrumentation & Pediatric Ergonomics

13.1 Standard Pediatric Acoustic Windows & Subcostal / Suprasternal Views 13.2 Transducer Selection, High Frequency Probes, Frame Rates & Pediatric Ergonomics 13.3 Patient Immobilization, Pediatric Sedation Protocols & Safety Considerations

14 Chapter 14: Doppler Hemodynamics, Bernoulli & Shunt Evaluation

14.1 Modified Bernoulli Equation, Peak vs Mean Gradients & Continuity Equation 14.2 Pulmonary-to-Systemic Flow Ratio (Qp:Qs) Calculations & Shunt Direction 14.3 Right Ventricular Systolic Pressure (RVSP) & Pulmonary Artery Pressure Estimation

15 Chapter 15: Chamber Quantification, Systolic & Diastolic Assessment

15.1 Pediatric Z-Score Methodology & BSA Indexing (Haycock/DuBois) 15.2 Left Ventricular Systolic Function: Simpson Biplane, 5/6 Area x Length & FS 15.3 Right Ventricular Quantitative Function: TAPSE, FAC & Tissue Doppler S' 15.4 Pediatric Diastolic Function Assessment: Mitral Inflow, Tissue Doppler & E/e'

16 Chapter 16: Advanced Modalities: Strain, 3D Echo & Saline Studies

16.1 Speckle Tracking Echocardiography & Global Longitudinal Strain (GLS) 16.2 Real-Time 3D Pediatric Echocardiography: En Face Valvular Imaging & Volume Assessment 16.3 Agitated Saline Bubble Studies, Ultrasound Enhancing Agents & Shunt Timing 16.4 Transesophageal (TEE) & Epicardial Echocardiography in Congenital Heart Surgery

11.3 Right Ventricle to Pulmonary Artery (RV-PA) Conduits & Ross Procedure

Key Takeaways Explain This Topic AI

The Ross procedure replaces a diseased aortic valve with the patient's native pulmonary root/valve (living autograft) and reconstructs the RVOT with a cryopreserved homograft, providing somatic growth potential without anticoagulation at the trade-off of creating potential two-valve disease.

Late failure modes of the Ross procedure include progressive autograft neoaortic root dilation (sinuses of Valsalva Z-score > +3.0 to +4.0), neoaortic valve regurgitation, and RVOT homograft calcification, stenosis, or insufficiency.

Extracardiac RV-PA conduits (cryopreserved homografts, bovine jugular vein Contegra, porcine valved Hancock conduits) universally degenerate over time due to somatic outgrowth, dystrophic calcification, neointimal peeling, and valvar cusp failure.

Comprehensive spectral Doppler interrogation requires multiplane continuous-wave alignment (high left parasternal, subcostal sagittal); severe conduit stenosis is defined by CW peak velocity >4.0 m/s (peak gradient >64 mmHg) or estimated RVSP > two-thirds systemic pressure.

Transcatheter Pulmonary Valve Replacement (TPVR; Melody and Edwards SAPIEN valves) provides a catheter-based solution for failing conduits; echocardiographic surveillance focuses on stent seating, strut fracture detection, residual gradients (<20-25 mmHg), paravalvular leaks, and infective endocarditis.

Last updated: September 2026

11.3 Right Ventricle to Pulmonary Artery (RV-PA) Conduits & Ross Procedure

Clinical Core: Surgical management of complex pediatric left and right heart lesions frequently necessitates replacing semilunar valves or establishing continuity between the right ventricle and pulmonary arteries using biological autografts, allografts, or heterografts. The Ross Procedure replaces a diseased aortic valve with the patient's living pulmonary autograft, offering somatic growth potential at the expense of creating two valve positions requiring lifelong surveillance. Concurrently, Right Ventricle to Pulmonary Artery (RV-PA) Conduits are required across a broad spectrum of congenital cardiac repairs (Truncus Arteriosus, TOF with Pulmonary Atresia, Rastelli, and Ross). Because all extracardiac conduits have a finite lifespan , mastering the Doppler quantification of conduit stenosis, conduit regurgitation, and Transcatheter Pulmonary Valve Replacement (TPVR) is a cornerstone of pediatric echocardiography.

Part 1: Extracardiac RV-to-PA Conduits

Extracardiac conduits are essential in pediatric cardiac surgery to bridge anatomical discontinuities between the right ventricle and the pulmonary arterial tree.

Types of Conduits

Cryopreserved Homografts (Allografts): Cryopreserved human cadaveric donor valves. Pulmonary homografts are preferred over aortic homografts because they exhibit lower rates of dystrophic calcification, less fibroelastic thickening, and longer structural durability. While they accommodate somatic growth in small infants better than rigid prosthetic rings, they lack living cellular repair mechanisms and do not grow with the patient.

Bovine Jugular Vein Conduits (Contegra): A natural bovine jugular vein segment containing an intact, competent trileaflet venous valve. Highly pliable and easily trimmed, with no rigid stent ring, making it ideal for infant RVOT reconstruction. However, it is uniquely susceptible to distal anastomotic intimal hyperplasia , aneurysmal dilation of the venous wall, and a pronounced predisposition to infective endocarditis .

Porcine Valved Dacron Conduits (Hancock): A glutaraldehyde-preserved porcine aortic valve mounted inside a woven Dacron prosthetic tube. Prone to severe calcific cusp immobilization, leaflet tearing, and the development of an inner neointimal peel that severely narrows the functional conduit lumen.

Non-Valved Polytetrafluoroethylene (PTFE / Gore-Tex) Conduits: Commonly utilized in neonates and small infants where small conduit caliber (<10 to 12 mm) precludes a functional valve. The resulting free pulmonary regurgitation is tolerated well in the short term, but mandates late valved conduit placement.

Mechanisms of Conduit Failure

Somatic Outgrowth: A conduit sized for an infant or small child (e.g., 10 to 12 mm) becomes relatively stenotic as the child grows into a larger body surface area, even in the complete absence of intrinsic tissue degeneration.

Dystrophic Calcification: Chronic mechanical stress, low-grade cell-mediated immune rejection, and calcium phosphate deposition induce progressive calcification of the conduit wall and valve cusps, causing rigid leaflet immobility and luminal narrowing.

Neointimal Peel & Fibroelastosis: Proliferation of a thick, fibrous, collagenous "peel" lining the inner lumen of synthetic or biological conduits creates circumferential subvalvar or supravalvar narrowing.

Valvular Regurgitation: Leaflet tear, prolapse, retraction, or calcific fixation results in free pulmonary regurgitation (PR), causing progressive right ventricular volume overload, RV dilation, and secondary tricuspid annular stretching.

Comprehensive Spectral Doppler Interrogation

To quantify conduit hemodynamics accurately, the sonographer must employ continuous-wave (CW) Doppler from multiple imaging windows (parasternal short-axis, high left parasternal, subcostal sagittal):

Peak Instantaneous Gradient: Derived using the modified Bernoulli equation: Δ P p e a k = 4 × ( V m a x ) 2 \Delta P_{peak} = 4 \times (V_{max})^2 Δ P p e ak ​ = 4 × ( V ma x ​ ) 2

Mean Pressure Gradient: Obtained by tracing the continuous-wave Doppler spectral envelope across systole: Δ P m e a n = Integrated Mean Systolic Gradient \Delta P_{mean} = \text{Integrated Mean Systolic Gradient} Δ P m e an ​ = Integrated Mean Systolic Gradient

Severity Thresholds for Conduit Stenosis:

Mild Stenosis: Peak velocity <3.0 m/s (peak gradient <36 mmHg).

Moderate Stenosis: Peak velocity 3.0 to 4.0 m/s (peak gradient 36 to 64 mmHg).

Severe Stenosis: Peak velocity >4.0 m/s (peak gradient >64 mmHg) or an estimated right ventricular systolic pressure (RVSP via TR jet) exceeding two-thirds of systemic pressure .

Differentiating Levels of Obstruction (PW Doppler Mapping): Sweep pulsed-wave Doppler along the conduit to distinguish:

  • Proximal obstruction at the RV-conduit ventriculotomy anastomosis,
  • Valvar stenosis at the conduit valve leaflets,
  • Distal stenosis at the pulmonary artery bifurcation anastomosis, or

Branch PA stenosis .

Catheter Interventions & Transcatheter Pulmonary Valve Replacement (TPVR)

To avoid repeated open-heart sternotomies, failing RV-PA conduits are frequently managed in the cardiac catheterization laboratory using balloon angioplasty, bare-metal stenting, and Transcatheter Pulmonary Valve Replacement (TPVR) .

TPVR Devices

Melody Valve (Medtronic): A bovine jugular vein valve sutured within a balloon-expandable platinum-iridium Cheatham-Platinum (CP) stent. Designed for conduit diameters between 16 and 22 mm.

SAPIEN Valve (Edwards Lifesciences): Bovine pericardial tissue mounted inside a balloon-expandable cobalt-chromium stent frame (SAPIEN XT or SAPIEN 3), capable of expanding into larger conduits and native RVOTs up to 29 mm.

Post-TPVR Echocardiographic Surveillance Protocol

Stent Seating and Position: Evaluate in parasternal short-axis, high parasternal, and subcostal views. The radiopaque stent appears as two bright, parallel echogenic lines in the RVOT. Confirm stable anchoring without proximal migration into the RV cavity or distal embolization into the pulmonary bifurcation.

Stent Fracture Detection: High-mechanical-stress RVOT environments can cause fatigue fractures of stent struts. On 2D and zoom imaging, identify any strut disruption, discontinuity, or inward strut protrusion that could cause leaflet damage.

Residual Transvalvular Gradient: Baseline CW Doppler should show marked gradient reduction (typical post-implant peak velocity 1.5 to 2.2 m/s, peak gradient <20 to 25 mmHg). A progressive rise in velocity on serial exams suggests stent compression, leaflet thrombosis, or endocarditis.

Paravalvular Leak (PVL) vs. Valvar Regurgitation: Color Doppler sweeps around the circumference of the stent frame distinguish a paravalvular leak (color jet originating outside the stent struts) from intravalvular regurgitation (central jet through dysfunctional leaflets).

Branch Pulmonary Artery Patency: Confirm that the distal stent rim does not protrude across or jail the origin of the left or right pulmonary artery.

Part 2: The Ross Procedure (Pulmonary Autograft)

Pioneered by Donald Ross in 1967, the Ross procedure is primarily indicated for severe congenital or acquired aortic stenosis and regurgitation in children and young adults where mechanical valve replacement is undesirable (to avoid lifelong systemic anticoagulation and permit somatic root growth): Ross Procedure Surgical Anatomy:

  • 1. Native Diseased Aortic Root/Valve ──► Excised and Discarded
  • 2. Native Pulmonary Root/Valve (Living Autograft) ──► Translocated to Systemic Aortic Position
  • 3. Coronary Artery Buttons ──► Re-implanted into Neoaortic Autograft
  • 4. Reconstructed RVOT ──► Cryopreserved Pulmonary or Aortic Homograft
  • Echocardiographic Surveillance Targets After the Ross Procedure

Autograft Neoaortic Root Dilation: Like the arterial switch operation, the native pulmonary root is exposed to systemic vascular pressures. Over time, progressive dilatation of the neo-annulus, neo-sinuses of Valsalva, and neo-sinotubular junction develops. Serial 2D measurements in the parasternal long-axis view must be indexed to BSA and tracked as Z-scores . Neoaortic root Z-scores exceeding +3.0 to +4.0 carry risk of aneurysm formation and leaflet coaptation failure.

Neoaortic Valve Regurgitation (AR): Progressive autograft regurgitation results from root dilation stretching the commissures, geometric leaflet distortion, or intrinsic cusp prolapse. Quantify AR via color jet width/LVOT diameter ratio, pressure half-time, and holodiastolic flow reversal in the descending abdominal aorta.

Coronary Button Patency: Interrogate the reimplanted coronary ostia and surveil the LV myocardium for regional wall motion abnormalities or reduced global longitudinal strain.

RV-PA Homograft Degeneration: The pulmonary or aortic allograft in the RVOT position is subject to chronic immunological reaction and dystrophic calcification, culminating in progressive stenosis, regurgitation, or combined disease.

Ross, Rastelli & Conduit Comparison Protocol

Feature Ross Procedure RV-PA Conduits (Homograft/Contegra) Transcatheter Pulmonary Valve (TPVR)

Primary Indication Aortic valve disease in children/young adults RVOT reconstruction in TOF, Truncus, Rastelli Failing stenotic or regurgitant conduit

  • Systemic Valve Native Pulmonary Autograft Native or Repaired Aortic Valve Native or Repaired Aortic Valve
  • RVOT Reconstruction Cryopreserved Homograft Homograft, Contegra, or Hancock Melody or SAPIEN Stented Valve
  • Anticoagulation Need None required None required Antiplatelet therapy (Aspirin)

Primary Failure Modes Autograft root dilation, AR, Homograft degeneration Calcification, neointimal peel, somatic outgrowth Stent fracture, Paravalvular leak, Endocarditis

Critical Doppler Sign Neoaortic PHT <200 ms, Homograft CW >3.5 m/s Peak velocity >4.0 m/s (ΔP >64 mmHg) Peak velocity >2.5 m/s , eccentric PVL jets

Infective Endocarditis Risk Moderate (homograft RVOT) High (especially bovine Contegra) Very High (bovine jugular Melody valve)

Clinical Pearls & Sonographic Traps

Warning

The Overestimated Conduit Gradient (Angle & Series Stenosis): When interrogating a curved extracardiac conduit, the velocity vector often changes direction across the ventriculotomy, valve, and distal anastomosis. Using a single transducer angle can severely misalign the Doppler beam. Furthermore, if a distal branch PA stenosis coexists with conduit valve stenosis, continuous-wave Doppler will superimpose both velocities, reporting an aggregate gradient. Always map with pulsed-wave Doppler to separate the conduit gradient from distal branch stenosis.

Tip

High Parasternal / Off-Axis Windows for RV-PA Conduits: Conduits are located immediately beneath the anterior chest wall and course superiorly and leftward. Standard apical and parasternal views often fail to align parallel to the conduit axis. Move the transducer one to two intercostal spaces higher on the left parasternal border and angle superiorly to achieve a pristine parallel intercept angle.

Note

Infective Endocarditis Vulnerability: Valved biological conduits (particularly bovine jugular vein Contegra conduits and Melody transcatheter valves) carry an extraordinarily high risk of infective endocarditis compared to native valves. Any new fever, unexplained rise in transconduit gradient, or worsening regurgitation mandates immediate, meticulous multiplane interrogation for mobile vegetations, stent sleeve abscesses, and leaflet destruction.

Loading diagram... Ross Procedure & RV-PA Conduit Surgical Mechanics, Failure Cascades & TPVR Checkpoints